Waverton Investment Management Ltd lowered its position in Colgate-Palmolive (NYSE:CL) by 11.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,254 shares of the company’s stock after selling 6,080 shares during the period. Waverton Investment Management Ltd’s holdings in Colgate-Palmolive were worth $2,872,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Moody National Bank Trust Division purchased a new stake in Colgate-Palmolive during the 4th quarter worth approximately $94,000. Price Capital Management Inc. purchased a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $121,000. O Brien Wealth Partners LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $123,000. IMS Capital Management grew its position in Colgate-Palmolive by 631.6% during the 3rd quarter. IMS Capital Management now owns 2,085 shares of the company’s stock worth $140,000 after purchasing an additional 1,800 shares during the last quarter. Finally, SRS Capital Advisors Inc. grew its position in Colgate-Palmolive by 61.1% during the 3rd quarter. SRS Capital Advisors Inc. now owns 2,475 shares of the company’s stock worth $166,000 after purchasing an additional 939 shares during the last quarter. 74.54% of the stock is currently owned by hedge funds and other institutional investors.

NYSE CL traded down $0.22 on Monday, hitting $61.88. 537,916 shares of the company’s stock traded hands, compared to its average volume of 4,859,508. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $77.91. The stock has a market cap of $53.17 billion, a price-to-earnings ratio of 21.56, a PEG ratio of 2.94 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 26th. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business had revenue of $3.85 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same period in the previous year, the business posted $0.73 EPS. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. Sell-side analysts forecast that Colgate-Palmolive will post 2.96 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 15th. Shareholders of record on Wednesday, January 23rd will be paid a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 2.71%. The ex-dividend date is Tuesday, January 22nd. Colgate-Palmolive’s payout ratio is 58.54%.

Several analysts have weighed in on CL shares. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday, October 29th. Argus reissued a “buy” rating and set a $75.00 target price (up previously from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Citigroup dropped their target price on shares of Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a research report on Monday, October 29th. Wells Fargo & Co dropped their target price on shares of Colgate-Palmolive from $62.00 to $58.00 and set a “market perform” rating on the stock in a research report on Monday, October 29th. Finally, SunTrust Banks downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the stock from $80.00 to $65.00 in a research report on Friday, October 26th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $67.87.

WARNING: This article was reported by Marea Informative and is owned by of Marea Informative. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.mareainformativa.com/news/2019/01/14/waverton-investment-management-ltd-has-2-87-million-stake-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

See Also: Capital gains and your 401(k) or IRA

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.